← Leaderboards
Steven Leiser
Psychogenics, Inc.
$538,405
Attributed
$538,405
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $450K · FY2019–20$500K$375K$250K$125K$0
'19
'20
Funding mix
By agency
NIH$538,405 · 1
By mechanism
R43$538,405 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Antipsychotic Agents”
- Abraham Aizer Brody · New York University School Of Medicine$22,358,187
- Joshua K Lin · Brigham And Women'S Hospital$5,160,288
- Chen Liu · Ut Southwestern Medical Center$3,262,428
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$3,167,795
- Thomas H Large · Blue Oak Pharmaceuticals, Inc.$2,984,866
- Jodi Jay Weinstein · State University New York Stony Brook$2,955,190
Research focus
Antipsychotic AgentsAuditory Evoked PotentialsBaseBehaviorBehavioralBehavioral ResponseBiological MarkersBrainBrain RegionCentral Nervous System DiseasesClinically RelevantClinical TrialsDatabasesDisease ModelDoseDrug ClassificationDrug DevelopmentDrug DiscoveryElectroencephalogramElectroencephalographyEnsureFaceFailureAnimal Model
Grant awards (2)
Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders$88,432
R43 · FY2020 · MH · contact PI
Development of a novel pharmaco-EEG based, high-throughput screening platform to facilitate drug discovery for psychiatric disorders$449,973
R43 · FY2019 · MH · contact PI